- Idea Cellular said it will continue to evaluate options to monetise Indus stake (Bloomberg).
- U.S. FDA maintains OAI status on Dr. Reddy's Srikakulam plant
- PNB denies the report that PWC is engaged in probing alleged fraud.
- BNP Paribas Arbitrage bought 0.8 percent equity in Fortis Healthcare at Rs 154.91 each.
Asian equities rose, extending a two-week global rally, after U.S. stocks posted strong gains and Treasury yields steadied. U.S. monetary policy is back in focus with two appearances from Federal Reserve Chairman Jerome Powell.
The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index's performance in India, rose 0.5 percent to 10,556.50 as of 6:59 a.m.
Here Are The Stocks To Watch Out For On Monday's Trade
- U.S. FDA maintains OAI (Official Action Indicated) status on Dr. Reddy's Srikakulam plant.
- Idea Cellular said it will continue to evaluate options to monetise Indus stake (Bloomberg).
- Bharti Airtel, Motorola partner to offer 4G smartphone.
- DCM Shriram to invest Rs 113 crore for expansion of Caustic soda capacity at its Bharuch facility.
- Sakuma Exports have submitted an expression of interest to acquire Ruchi Soya.
- Sadbhav Infra unit Bhilwara-Rajsamanad tollway completes debt refinancing.
- Idea Cellular raises Rs 3,500 crore via QIP.
- Dena Bank sets issue price at Rs 26.89 per share for issue of shares to the government.
- PNB denies report that PWC is engaged in probing alleged fraud.
- Welspun Enterprises said it is lowest bidder for NHAI Tamil Nadu road project.
- Government asks HUL to explain math behind Rs 119 crore profiteered sum
There's a new deadline for launch of #GST e-way bills. https://t.co/nAo3CsMs7j pic.twitter.com/W2AVNrxyE2
Bulk Deals
- Fortis Healthcare: BNP Paribas Arbitrage bought 42.75 lakh shares or 0.8 percent equity at Rs 154.91 each.
- Apollo Pipes: Laburnum capital advisors bought 67,000 shares, or 0.6 percent equity at Rs 561.99 each.
- Finolex Industries: Prescient Wealth Management Private Limited sold 7.98 lakh shares, or 0.6 percent equity at Rs 629 each.
- Chembond Chemicals: Promoter Perviz Homi Dastur sold 1.30 lakh shares, or 1 percent equity at Rs 297.4 each.
- Jaypee Infratech: IndusInd Bank Ltd. Client A/c sold 1.1 crore shares, or 0.8 percent equity at Rs 13.65 each.
- Dollar Industries: Shakuntala Exim Pvt Ltd. sold 3 lakh shares, or 0.5 percent equity at Rs 420.3 each.
Jubilant Lifesciences
- Copthall Mauritius Investment bought 27.50 lakh shares, or 1.7 percent equity at Rs 914 each.
- Promoter Jubilant Advisors LLP sold 22.38 lakh shares, or 1.4 percent equity at Rs 917.43 each.
- Promoter Jubilant Consumer Pvt Ltd sold 27.36 lakh shares, or 1.7 percent equity at Rs 914 each.
Shiva Texyarn
- Care Portfolio managers bought 78,000 shares, or 0.6 percent equity at Rs 540 each.
- Promoter S V Kandasami sold 1.31 lakh shares, or 1 percent equity at Rs 543.11 each.
Why the world's highest paid expats are making a beeline for India.https://t.co/J7Cdte3bg2 pic.twitter.com/xavJxbNA2Z
New Offerings/Listings
- H.G. Infra Engineering IPO opens today with an issue Price: Rs 263 - Rs 270 per equity share.
- Aster DM Healthcare lists today with a base price of Rs 190 per share. Its IPO was subscribed 13 times.
HG Infra IPO Opens Today: Here's all you need to knowhttps://t.co/VBVszWuBM8 pic.twitter.com/jx6iFxD91C
Trading Tweaks
- Gini Silk Mills circuit filter revised to 5 percent.
- FDC ex-date for determining buyback eligibility.
Insider Trades
- Chambal Fertilizer promoter Nandini Nopany sold 2.55 lakh shares on Feb. 22.
- Apollo tyres promoter Neeraj Consultants acquired 2.40 lakh shares on Feb. 22.
- Lumax Industries promoters acquired 5,000 shares on Feb. 19.
- MM Forgings promoter S Lakshman sold 563 shares on Feb. 22.
- Om Metals Infraprojects promoter Jupiter Metal acquired 10,000 shares on Feb. 22.
- Gateway Distriparks promoter Prem Kishan Gupta acquired 6 lakh shares on Feb. 21.
- Gallant Metal promoter Hipolin Commerce acquired 19,152 shares on Feb. 21.
Axis bank is one of the worst-affected in the private sector after the Reserve Bank's asset quality review. https://t.co/0PI4fRfE0R pic.twitter.com/ETdDGQbHh3
F&O Cues
- Nifty March Futures closed trading at 10,504.5, premium of 13 points versus 6 points.
- All series-Nifty OI up 5 percent, Bank Nifty OI up 5 percent.
- India VIX ended at 14.2, down 4 percent.
- Max OI for March series at 10,700 call strike , OI at 29 lakh, OI up 16 percent.
- Max OI for March series at 10,000 Put, OI at 35.4lk, up 9 percent.
F&O Ban
- In Ban: Fortis Healthcare and JP Associates.
- New In Ban: Fortis Healthcare and JP Associates.
Alert: Only intraday positions can be taken in stocks which are in F&O ban. There is a penalty in case of rollover of these intraday positions.
Put-Call Ratio
- Nifty PCR at 1.43 versus 1.18.
- Nifty Bank PCR at 1.24 versus 0.89.
Fund Flows
Brokerage Radar
HSBC on ICICI Lombard
- Initiated ‘Reduce' with price target of Rs 610; implying a potential downside of 25 percent form last regular trade.
- Gross written premium to grow slower than industry rate due to competition.
- High dependency on three segments – motor, crop and health insurance.
- Life players could enter the health market.
- Three regions account for 48 percent of its premiums.
- Emergence of a stronger competitor is a possibility.
- Profitability to improve due to fall in the loss ratio.
- Expect net income to compound at 29 percent over the fiscal 2017-2020.
- Passage of the motor vehicle bill is the key upside risk.
- Stock trades at a high valuation.
CLSA on Supreme Industries
- Initiated ‘Buy' with price target of Rs 1,482; implying a potential upside of 25 percent from yesterday's close.
- Impressive growth track record with superlative capital returns.
- Diversified product offering; Focusing on value-added products.
- Efficient capital allocation; Generated superlative ROCEs in capital-intensive industry.
- Expect free cash flow with balance sheet to turn net cash by March 2020.
- Expect earnings per share to compound at 25 percent through the financial years till March 2020.
- Deserves to trade at premium.
Nomura on Sun Pharma
- Maintained ‘Neutral' with price target of Rs 479.
- Number of observations limited to three for a large plant inspected over two weeks.
- Appears to be a good outcome.
- Difficult to predict timelines for FDA action; Expect issuance of EIR to take six months.
- Outcome of Halol FDA inspection is not a significant positive, given current expectations.
- Key for Sun Pharma is trajectory of the specialty business.
Jefferies on Sun Pharma
- Maintained ‘Hold' with price target of Rs 520.
- Halol gets 3 observations; Severity unknown.
- Halol resolution is a key near-term trigger for Sun Pharma.
- Halol is key driver to earnings recovery; Expect resolution in current quarter.
- Earnings recovery to be gradual as investment in specialty to continue.
IDFC Securities United Spirits
- Maintained ‘Neutral' with price target of Rs 3,336.
- Impact from route to market (RTM) to recede in the current quarter.
- Franchise benefits to accrue through March 2018.
- Lower molasses prices to benefit near term margins.
- Remain positive on broader premiumisation and return and margin-accretive growth strategy.
- Valuations leave little room for upside; Await better entry point.
IDFC Securities on Redington India
- Maintained ‘Outperform' with price target of Rs 224.
- India IT enterprise business could pick up pace.
- Change in leadership at Apple India would be positive.
- India business to be driven by Enterprise/non-Apple Mobility.
- India Working capital (WC) to improve; Overseas WC not sustainable.
- Scaling up a priority for ProConnect; Open to listing ProConnect.
IDFC Securities on United Breweries
- Maintained ‘Outperform' with price target of Rs 1,333
- Volume trajectory to remain healthy in the current quarter.
- Early signs of rationalising competitive intensity.
- Market share gains could continue.
- Expect strong double-digit volume growth over next two quarters.
- Healthy growth outlook; attractive valuations.
Goldman Sachs says stocks may plunge 25% if 10-year yield hits 4.5%.https://t.co/yPUm7PEQwm pic.twitter.com/Lc9USzmFwT
Media Reports
- JSW Steel to buy Italian steel firm Aferpi for Rs 600 crore. (Business Standard).
- Jaypee Infra bidders offer upfront pay, loan-land swap (Times of India).
- RBI tells banks to tighten internal controls (Mint).
- SBI set for U.K. restructuring (PTI).
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
.png)